On 10/31/24, MiMedx Group Inc (NASDAQ: MDXG) stock enjoyed a major increase of 20.4%, closing at $6.85. Moreover, this advance was accompanied by exceptionally high trading volume at 301% of normal. Relative to the market the stock has been weak over the last nine months but has risen 21.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, MDXG is expected to continue to be a major Value Builder.
MiMedx Group has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. MiMedx Group has a poor Appreciation Score of 17 and a poor Power Rating of 17, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment